BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Adembri C, Novelli A, Nobili S. Some Suggestions from PK/PD Principles to Contain Resistance in the Clinical Setting-Focus on ICU Patients and Gram-Negative Strains. Antibiotics (Basel) 2020;9:E676. [PMID: 33036190 DOI: 10.3390/antibiotics9100676] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Gatti M, Cojutti PG, Bartoletti M, Tonetti T, Bianchini A, Ramirez S, Pizzilli G, Ambretti S, Giannella M, Mancini R, Siniscalchi A, Viale P, Pea F. Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients. Crit Care 2022;26:178. [PMID: 35701812 DOI: 10.1186/s13054-022-04050-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Bavaro DF, Belati A, Diella L, Stufano M, Romanelli F, Scalone L, Stolfa S, Ronga L, Maurmo L, Dell'Aera M, Mosca A, Dalfino L, Grasso S, Saracino A. Cefiderocol-Based Combination Therapy for "Difficult-to-Treat" Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives. Antibiotics (Basel) 2021;10:652. [PMID: 34072342 DOI: 10.3390/antibiotics10060652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Gaibani P, Gatti M, Rinaldi M, Crovara Pesce C, Lazzarotto T, Giannella M, Lombardo D, Amadesi S, Viale P, Pea F, Ambretti S. Suboptimal drug exposure leads to selection of different subpopulations of ceftazidime-avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in a critically ill patient. Int J Infect Dis 2021;113:213-7. [PMID: 34656787 DOI: 10.1016/j.ijid.2021.10.028] [Reference Citation Analysis]
4 Gatti M, Cojutti PG, Pascale R, Tonetti T, Laici C, Dell'Olio A, Siniscalchi A, Giannella M, Viale P, Pea F. Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections. Antibiotics (Basel) 2021;10:1311. [PMID: 34827249 DOI: 10.3390/antibiotics10111311] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
5 Karvouniaris M, Pontikis K, Nitsotolis T, Poulakou G. New perspectives in the antibiotic treatment of mechanically ventilated patients with infections from Gram-negatives. Expert Rev Anti Infect Ther 2021;19:825-44. [PMID: 33270485 DOI: 10.1080/14787210.2021.1859369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Garduno A, Martín-Loeches I. Efficacy and appropriateness of novel antibiotics in response to antimicrobial-resistant Gram-negative bacteria in patients with sepsis in the ICU. Expert Rev Anti Infect Ther 2021. [PMID: 34727820 DOI: 10.1080/14787210.2022.1999804] [Reference Citation Analysis]